威高股份(1066.HK)临时股东大会高票通过此前已披露的中期股息每股0.0854元，属程序性表决无新增信息

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong
Kong Limited take no responsibility for the contents of this announcement, make no
representation as to its accuracy or completeness and expressly disclaim any liability
whatsoever for any loss howsoever arising from or in reliance upon the whole or any
part of the contents of this announcement.

山東威高集團醫用高分子製品股份有限公司

Shandong Weigao Group Medical Polymer Company Limited *
(a joint stock limited company incorporated in the People’s Republic of China with limited liability)

(Stock Code: 1066)

POLL RESULTS OF 2026 SECOND EXTRAORDINARY
GENERAL MEETING HELD ON 16 OCTOBER 2026
AND
PAYMENT OF INTERIM DIVIDEND
SUMMARY
The EGM of the Company were duly held on 16 October 2026. The Board is pleased
to announce that all the resolutions as set out in the Notice of EGM were duly passed
by way of poll.
Reference is made to the interim report (the “Interim Report”), the circular (the
“ Circular ” ) and the notice of the extraordinary general meeting (the “ EGM ” )
(“Notice of EGM”) of Shandong Weigao Group Medical Polymer Company Limited
(the “ Company ” ), all dated 28 September 2026. Capitalised terms used in this
announcement shall have the same meanings as those defined in the Circular unless the
context requires otherwise.

1

POLL RESULTS OF THE EGM
All the resolution set out in the Notice of EGM were passed by way of poll. The poll
results of the resolution are as follows:
Number of votes cast and
approximate percentage
(%) of total number of
votes cast

ORDINARY RESOLUTION

For
1.

To consider and approve the distribution of 3,266,542,756
an interim dividend of RMB0.0854 per Share
(99.99%)
(inclusive of tax) for the six months ended 30
June 2026.

Against
359,275
(0.01%)

As more than one half of the votes were casted in favour of resolution numbered (1),
such resolution was duly passed by way of poll as ordinary resolution of the Company.
At the date of the EGM, the total number of Shares entitling the Shareholders to attend
and vote for or against the resolutions at the EGM was 4,455,407,524 Shares, all of
which were H Shares (but excluding 66,924,800 treasury shares). There were no Shares
entitling the holders to attend and vote only against the resolutions proposed at the
EGM. Trustee who administers share award scheme of the Company did not exercise
the voting rights attached to any of the 14,456,000 H Shares and 48,300,000 Domestic
Shares under the share award scheme.
The EGM was chaired by Mr. Long Jing. All Directors attended the EGM.
威海朗普聯合會計師事務所（普通合夥）(Weihai Langpu United Certified Public
Accountants (General Partnership))*, certified public accountants in the PRC and the
auditor of the Company in the PRC, was appointed as the scrutineer for the vote-taking
at the EGM.

2

INTERIM DIVIDEND PAYMENT
Further to the Interim Report and the Circular, the Company will distribute a pre-tax
interim dividend of RMB0.0854 per Share for the six months ended 30 June 2026 to
all the Shareholders whose names appear on the register of members of the Company
on 23 October 2026. According to the Articles of Association, dividends will be
denominated and declared in RMB. Dividends for Hong Kong Stock Connect and
“Full Circulation” of H shares will be paid in RMB, and dividends on other H Shares
will be paid in Hong Kong dollar. The relevant exchange rate is based on the average
middle exchange rate of Hong Kong dollar to Renminbi as quoted by the People’s
Bank of China for the calendar week preceding 16 October 2026, the date on which the
dividend was declared, being HK$1.00 to RMB0.8574. Therefore, the pre-tax dividend
per H Share of the Company, being RMB0.0854, will be HK$0.0996.
The Company has appointed Bank of China (Hong Kong) Limited and China Securities
Depository and Clearing Corporation Limited as the receiving agent (the “Receiving
Agent”) for the holders of H Shares. The Receiving Agent will dispatch dividends
payable to holders of H Shares on or before 20 November 2026 by ordinary mail which
shall be posted at the risk of the recipients.
By order of the Board
Shandong Weigao Group Medical Polymer Company Limited
Long Jing
Chairman
Weihai, Shandong, the PRC, 16 October 2026

As at the date of this announcement, the Board comprises:
Executive Directors
Mr. Long Jing (Chairman)
Mr. Cong Rinan (Chief Executive Officer)
Mr. Lu Junqiang
Mr. Wang Daoming

3

Non-executive Directors
Mr. Chen Lin
Mr. Tang Zhengpeng
Independent non-executive Directors
Mr. Li Guohui
Mrs. Meng Hong
Mr. Li Qiang
Mr. Sun Heng
* for identification purpose only

4